Clinical trial
Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure
NCT03598465 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating the Association Between Sphingolipid Metabolites and Post-hepatectomy Liver Failure
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 5, 2019
- Completion date
- October 1, 2024
- Enrollment
- 591 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
post-hepatectomy liver failure